These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19473180)

  • 1. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.
    Reid TJ; Post KD; Bruce JN; Nabi Kanibir M; Reyes-Vidal CM; Freda PU
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):203-8. PubMed ID: 19473180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognizing the clinical manifestations of acromegaly: case studies.
    Iuliano SL; Laws ER
    J Am Assoc Nurse Pract; 2014 Mar; 26(3):136-42. PubMed ID: 24170330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has acromegaly been diagnosed earlier?
    Ohno H; Yoneoka Y; Jinguji S; Watanabe N; Okada M; Fujii Y
    J Clin Neurosci; 2018 Feb; 48():138-142. PubMed ID: 29113856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuation analysis of postoperative secretory status in patients operated for acromegaly.
    Graillon T; Castinetti F; Boucekine M; Cuny T; Morange I; Fuentes S; Figarella-Branger D; Albarel F; Brue T; Dufour H
    Ann Endocrinol (Paris); 2020 Feb; 81(1):11-17. PubMed ID: 31982107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
    Kinoshita Y; Tominaga A; Usui S; Arita K; Sakoguchi T; Sugiyama K; Kurisu K
    Neurosurg Rev; 2016 Apr; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of transsphenoidal surgery on sleep apnoea in acromegaly.
    Sze L; Schmid C; Bloch KE; Bernays R; Brändle M
    Eur J Endocrinol; 2007 Mar; 156(3):321-9. PubMed ID: 17322492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.
    Freda PU; Reyes CM; Nuruzzaman AT; Sundeen RE; Bruce JN
    Pituitary; 2003; 6(4):175-80. PubMed ID: 15237928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register.
    Petersenn S; Buchfelder M; Gerbert B; Franz H; Quabbe HJ; Schulte HM; Grussendorf M; Reincke M;
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):400-5. PubMed ID: 19226273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Acromegaly in Patients with Carpal Tunnel Syndrome: A Prospective Study (ACROCARP).
    Zoicas F; Kleindienst A; Mayr B; Buchfelder M; Megele R; Schöfl C
    Horm Metab Res; 2016 Jul; 48(7):452-6. PubMed ID: 26849823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene.
    Schmid C; Krayenbuehl PA; Bernays RL; Zwimpfer C; Maly FE; Wiesli P
    Clin Chem; 2007 Aug; 53(8):1484-8. PubMed ID: 17573420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acromegaly and it's cardiovascular implications].
    Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study.
    Varadhan L; Reulen RC; Brown M; Clayton RN
    Pituitary; 2016 Jun; 19(3):251-61. PubMed ID: 26724807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the thyrotropin-releasing hormone test in pre-clinical acromegaly.
    Kageyama K; Moriyama T; Sakihara S; Takayasu S; Nigawara T; Suda T
    Tohoku J Exp Med; 2005 Aug; 206(4):291-7. PubMed ID: 15997199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegaly.
    Grottoli S; Gasco V; Mainolfi A; Beccuti G; Corneli G; Aimaretti G; Dieguez C; Casanueva F; Ghigo E
    J Endocrinol Invest; 2008 Dec; 31(12):1103-9. PubMed ID: 19246978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment.
    Campana C; Cocchiara F; Corica G; Nista F; Arvigo M; Amarù J; Rossi DC; Zona G; Ferone D; Gatto F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):789-801. PubMed ID: 33236108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.